Description

This issue of Vital Signs, released on April 13, 2009, provides an analysis of feedback on evolving strategies and areas of future interest from members of the pharmaceutical, biotechnology and diagnostics community. Additionally, a company spotlight is provided for Signature Genomic Laboratories, a provider of microarray-based comparative genomic hybridization (aCGH) diagnostic products and services. Reimbursement and regulatory news from the FDA is also provided for March 30, 2009.